Literature DB >> 22498601

China's stem-cell rules go unheeded.

David Cyranoski.   

Abstract

Mesh:

Year:  2012        PMID: 22498601     DOI: 10.1038/484149a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Stem-cell fraud hits febrile field.

Authors:  David Cyranoski
Journal:  Nature       Date:  2012-10-18       Impact factor: 49.962

2.  Chinese newspaper coverage of (unproven) stem cell therapies and their providers.

Authors:  Ubaka Ogbogu; Li Du; Christen Rachul; Lisa Bélanger; Timothy Caulfield
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

3.  Bioethics in practice: a quarterly column about medical ethics: stem cell ethics.

Authors:  Deryk Jones
Journal:  Ochsner J       Date:  2013

4.  Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke.

Authors:  Michael G Liska; Marci G Crowley; Cesar V Borlongan
Journal:  Transl Stroke Res       Date:  2017-01-26       Impact factor: 6.829

Review 5.  Development and regulation of stem cell-based therapies in China.

Authors:  Jianchao Gao; Chenyan Gao
Journal:  Cell Prolif       Date:  2022-04-13       Impact factor: 8.755

6.  The 'credibility paradox' in China's science communication: Views from scientific practitioners.

Authors:  Joy Yueyue Zhang
Journal:  Public Underst Sci       Date:  2015-08-24

Review 7.  Developing standards to support the clinical translation of stem cells.

Authors:  Jiani Cao; Jie Hao; Lei Wang; Yuanqing Tan; Yuchang Tian; Shiyu Li; Aijin Ma; Boqiang Fu; Jianwu Dai; Peijun Zhai; Peng Xiang; Yong Zhang; Tao Cheng; Yaojin Peng; Qi Zhou; Tongbiao Zhao
Journal:  Stem Cells Transl Med       Date:  2021-11       Impact factor: 6.940

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.